AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene PPP3R1andWDR92.
, go to our main page or see our latest news
Homo sapiens complex locus PPP3R1andWDR92, encoding protein phosphatase 3, regulatory subunit B, alpha and WD repeat domain 92.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 225 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in brain (seen 17 times), liver and spleen (9), testis (9), uterus (9), stomach (8), adrenal gland (6), eye (6), germinal center B cell (6), hippocampus (6), placenta cot 25-normalized (6), colon ins (5), lung (5), normal nasopharynx (5), placenta (5), skin (5), colon (4), fetal brain (4), nervous normal (4), neuroblastoma (4), retina (4), small intestine (4), amygdala (3), breast carcinoma (3), breast normal (3), coronary artery (3), pooled germ cell tumors (3), cervix (2), duodenal adenocarcinoma, cell line (2), embryonic stem cells, dmso-treated H9 cellline (2), hepatocellular carcinoma (2), human embryonic stem cells (2), human embryonic stem cells differentiated toan early endodermal cell type (2), kidney (2), leiomyosarcoma (2), leiomyosarcoma cell line (2), leukopheresis (2), melanotic melanoma (2), myeloma (2), nervous tumor (2), neuroblastoma cells (2), neuroblastoma cot 50-normalized (2), ovary (2), T cells from T cell leukemia (2), whole brain (2), adenocarcinoma (once), adenocarcinoma cell line (once), adrenal cortex carcinoma, cell line (once), ascites (once), b-cells (once), beard hair (once), bladder, transitional cell papilloma (once), blastocyst (once), blood vessels - aorta, basilar and artery (once), blood, adult leukocytes (once), brain stem and basal ganglia (once), brain, neuroblastoma (once), brain/cns (once), breast (once), carcinoid (once), caudate nucleus (once), cerebellum (once), embryonal carcinoma, cell line (once), embryonic stem (once), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (once), embryonic stem cells (once), embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells (once), glioblastoma (pooled) (once), head normal (once), heart (once), human brain - frontal cortex (once), human lung epithelial cells (once), hypothalamus (once), liver (once), lymph (once), lymphoma, cell line (once), mammary adenocarcinoma, cell line (once), melanotic melanoma, high MDR (once), metastatic chondrosarcoma (once), neuroblastoma cot 25-normalized (once), ovarian tumor (once), ovary (pool of 3) (once), pancreas (once), placenta normal (once), pluripotent cell line derived fromblastocyst inner cell mass (once), pooled human melanocyte, fetal heart, andpregnant uterus (once), poorly differentiated adenocarcinoma withsignet ring cell features (once), primary b-cells from tonsils (once), primary b-cells from tonsils (cell line) (once), prostate normal (once), prostate tumor (once), retinoblastoma (once), rpe/choroid (once), schizophrenic brain S-11 frontal lobe (once), sciatic nerve (once), senescent fibroblast (once), serous papillary carcinoma, high grade, 2pooled tumors (once), skin, melanotic melanoma (once), spleen (once), stomach normal (once), T cells (jurkat cell line) cot10-normalized (once), thalamus (once), thymus (once), trachea (once), tumor (once), white matter (once).
225 cDNA clones support the 15 variants of gene PPP3R1andWDR92
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AY183476 | | .a | 1 to 2306 | 1 to 2298 | F390L G392F C393L R394G F395A ... | tiling clone, | Suspected internal deletion | 2298/2298 (100 %) | 0 diff (100 %id) |
CD689724 | normal nasopharynx | .a | 1116 to 1776 | 33 to 693 | | | | 661/693 (95 %) | 6 diff (99.2 %id) |
BP271204 | small intestine | .a | 1116 to 1696 | 1 to 581 | | | | 581/581 (100 %) | 1 diff (99.9 %id) |
CD710195 | normal nasopharynx | .a | 1120 to 1545 | 1 to 427 | | | | 427/427 (100 %) | 5 diff (98.9 %id) |
BF691906 | melanotic melanoma, high MDR, skin | .a | 1120 to 1231 | 1 to 112 | | | | 112/112 (100 %) | 1 diff (99.2 %id) |
BP348185 | brain | .a | 1121 to 1705 | 1 to 586 | | | | 586/586 (100 %) | 3 diff (99.5 %id) |
BU858593 | mixed (pool of 40 RNAs) | .a | 1123 to 1900 | 1 to 785 | | | | 782/789 (99 %) | 13 diff (98.4 %id) |
CB130729 | Liver | .a | 1128 to 1467 | 1 to 340 | | | | 340/340 (100 %) | 3 diff (99.2 %id) |
BX381999 | Placenta Cot 25-normalized | .a | 1138 to 1989 | 1 to 847 | | fully sequenced, | | 847/847 (100 %) | 12 diff (98.6 %id) |
DA666008 | | .a | 1142 to 1697 | 2 to 558 | | capped | | 557/557 (100 %) | 2 diff (99.7 %id) |
BM788338 | stomach | .a | 1142 to 1765 | 1 to 623 | | | | 623/623 (100 %) | 1 diff (99.9 %id) |
DA562147 | heart | .a | 1143 to 1703 | 2 to 562 | | capped | | 561/561 (100 %) | 0 diff (100 %id) |
BP425990 | small intestine | .a | 1143 to 1381 | 1 to 239 | | | Submitted on the opposite strand | 239/239 (100 %) | 0 diff (100 %id) |
DB076330 | testis | .a | 1143 to 1711 | 2 to 571 | | capped | | 570/570 (100 %) | 2 diff (99.7 %id) |
BM786368 | Ascites, stomach | .a | 1144 to 1642 | 1 to 499 | | | | 499/499 (100 %) | 0 diff (100 %id) |
CX784076 | human embryonic stem cells | .a | 1145 to 1660 | 1 to 516 | | | | 516/516 (100 %) | 0 diff (100 %id) |
DA547016 | | .a | 1147 to 1698 | 8 to 559 | | capped | | 552/552 (100 %) | 0 diff (100 %id) |
AY541587 | hepatocellular carcinoma | .a | 1149 to 2444 | 9 to 1305 | | AAA | Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) | 1297/1305 (99 %) | 9 diff (99.4 %id) |
AK056303 | | .a | 1152 to 3395 | 1 to 2247 | | tiling clone, available from FLJ, | | 2247/2248 (99 %) | 2 diff (100.0 %id) |
CD692630 | normal nasopharynx | .a | 1152 to 1673 | 23 to 545 | | | | 523/545 (95 %) | 15 diff (97.3 %id) |
NM_138458.2 | | .a | 1152 to 3395 | 1 to 2244 | | RefSeq, | | 2244/2244 (100 %) | 0 diff (100 %id) |
DA371631 | thalamus | .a | 1153 to 1700 | 2 to 550 | | capped | | 549/549 (100 %) | 1 diff (99.9 %id) |
DA703926 | | .a | 1153 to 1717 | 2 to 567 | | capped | | 566/566 (100 %) | 1 diff (99.9 %id) |
DB258584 | uterus | .a | 1153 to 1707 | 2 to 557 | | capped | | 556/556 (100 %) | 1 diff (99.9 %id) |
BM754606 | stomach | .a | 1154 to 1379 | 1 to 226 | | | | 226/226 (100 %) | 3 diff (98.7 %id) |
BM151799 | leukopheresis | .a | 1155 to 1496 | 1 to 342 | | | | 342/342 (100 %) | 6 diff (98.3 %id) |
BG468945 | adenocarcinoma cell line, colon | .a | 1156 to 1620 | 1 to 465 | | | | 465/466 (99 %) | 6 diff (98.8 %id) |
BM152242 | leukopheresis | .a | 1157 to 1432 | 6 to 282 | | | | 277/282 (98 %) | 6 diff (97.9 %id) |
BX437940 | neuroblastoma | .a | 1160 to 2245 | 1 to 1082 | | | | 1082/1099 (98 %) | 12 diff (99.0 %id) |
DA125524 | cerebellum | .a | 1161 to 1753 | 2 to 594 | | capped | | 593/598 (99 %) | 2 diff (99.7 %id) |
BC020271 | Brain, neuroblastoma | .a | 1162 to 2608 | 1 to 1447 | | available from MGC, AAA | Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) | 1447/1447 (100 %) | 1 diff (100.0 %id) |
BF972430 | leiomyosarcoma cell line, uterus | .a | 1162 to 1867 | 1 to 709 | | | | 711/990 (71 %) | 28 diff (97.2 %id) |
BI752832 | brain | .a | 1162 to 1907 | 1 to 745 | | | | 745/745 (100 %) | 5 diff (99.4 %id) |
CX163298 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 1162 to 2012 | 13 to 862 | | fully sequenced, | Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) | 850/862 (98 %) | 7 diff (99.2 %id) |
BG337996 | leiomyosarcoma cell line, uterus | .a | 1163 to 1867 | 1 to 705 | | | | 705/709 (99 %) | 13 diff (98.2 %id) |
BC066657 | Skin, melanotic melanoma. | .a | 1166 to 2608 | 1 to 1443 | | available from MGC, AAA | Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) | 1443/1443 (100 %) | 1 diff (100.0 %id) |
BU177986 | melanotic melanoma, skin | .a | 1168 to 2007 | 1 to 850 | | | | 850/894 (95 %) | 16 diff (98.3 %id) |
TI_57214972 | | .a | 1169 to 1907 | 47 to 797 | | | | 764/797 (95 %) | 59 diff (92.6 %id) |
BM474873 | duodenal adenocarcinoma, cell line, small intestine | .a | 1171 to 2001 | 13 to 847 | | | | 839/950 (88 %) | 14 diff (98.6 %id) |
BM474935 | duodenal adenocarcinoma, cell line, small intestine | .a | 1171 to 2007 | 13 to 855 | | | | 847/1024 (82 %) | 18 diff (98.3 %id) |
BF314904 | brain, neuroblastoma | .a | 1175 to 1867 | 1 to 682 | | available from MGC, | | 682/886 (76 %) | 15 diff (98.4 %id) |
CN310815 | embryonic stem cells, DMSO-treated H9 cellline | .a | 1178 to 1929 | 7 to 760 | | | | 754/760 (99 %) | 2 diff (99.8 %id) |
BX399718 | Placenta Cot 25-normalized | .a | 1181 to 2102 | 19 to 940 | | | | 922/1048 (87 %) | 16 diff (98.5 %id) |
DA148534 | amygdala | .a | 1184 to 1752 | 2 to 570 | | capped | | 569/569 (100 %) | 0 diff (100 %id) |
BF663850 | B-cells, primary B-cells from tonsils (cell line) | .a | 1193 to 1860 | 1 to 665 | | | | 665/672 (98 %) | 16 diff (97.7 %id) |
CD684446 | normal nasopharynx | .a | 1196 to 1856 | 33 to 695 | | | | 663/695 (95 %) | 10 diff (98.6 %id) |
CD705377 | normal nasopharynx | .a | 1196 to 1552 | 27 to 383 | | | | 357/383 (93 %) | 6 diff (98.5 %id) |
DB249319 | uterus | .a | 1197 to 1740 | 2 to 545 | | capped | | 544/544 (100 %) | 0 diff (100 %id) |
BM545156 | ovary (pool of 3) | .a | 1198 to 2242 | 27 to 1076 | | | | 1050/1138 (92 %) | 18 diff (98.5 %id) |
DN991215 | brain, whole brain | .a | 1202 to 1814 | 8 to 621 | | | | 614/621 (98 %) | 7 diff (98.9 %id) |
ES308070 | beard hair, skin | .a | 1205 to 1394 | 1 to 190 | | | | 190/193 (98 %) | 1 diff (99.5 %id) |
DR762355 | embryonic stem | .a | 1207 to 1993 | 1 to 787 | | | | 787/787 (100 %) | 1 diff (99.9 %id) |
DB446707 | testis | .a | 1218 to 1641 | 1 to 424 | | | | 424/424 (100 %) | 1 diff (99.8 %id) |
TI_1948225139 | | .a | 1231 to 2098 | 994 to 123 | | | | 872/1378 (63 %) | 31 diff (97.8 %id) |
TI_1948224503 | | .a | 1232 to 1928 | 155 to 861 | | | | 707/1282 (55 %) | 31 diff (97.6 %id) |
TI_1948224504 | | .a | 1232 to 2098 | 991 to 128 | | | | 864/1369 (63 %) | 34 diff (97.6 %id) |
TI_1948224805 | | .a | 1232 to 1490 | 125 to 383 | | | | 259/285 (90 %) | 7 diff (97.6 %id) |
TI_1948224808 | | .a | 1232 to 2098 | 993 to 127 | | | | 867/1320 (65 %) | 6 diff (99.6 %id) |
TI_1948225137 | | .a | 1232 to 2102 | 126 to 993 | | | | 868/1416 (61 %) | 32 diff (97.8 %id) |
TI_1948225455 | | .a | 1232 to 2098 | 124 to 989 | | | | 866/1437 (60 %) | 11 diff (99.3 %id) |
TI_1948225456 | | .a | 1232 to 1848 | 151 to 776 | | | | 626/1482 (42 %) | 25 diff (98.4 %id) |
TI_1948225458 | | .a | 1232 to 2098 | 1003 to 126 | | | | 878/1323 (66 %) | 14 diff (99.0 %id) |
EL735979 | mixed | .a | 1233 to 1851 | 1 to 619 | | | | 619/619 (100 %) | 1 diff (99.9 %id) |
AL514670 | neuroblastoma, placenta | .a | 1260 to 2210 | 1 to 986 | | fully sequenced, | | 986/986 (100 %) | 37 diff (96.3 %id) |
TI_1948224807 | | .a | 1263 to 2098 | 961 to 122 | | | | 840/1451 (57 %) | 10 diff (99.4 %id) |
BF807083 | colon_ins | .a | 1277 to 1633 | 363 to 9 | | | Submitted on the opposite strand | 355/363 (97 %) | 1 diff (99.8 %id) |
BF807087 | colon_ins | .a | 1277 to 1627 | 350 to 1 | | | Submitted on the opposite strand | 350/350 (100 %) | 4 diff (98.9 %id) |
BF807282 | colon_ins | .a | 1277 to 1633 | 363 to 9 | | | Submitted on the opposite strand | 355/363 (97 %) | 1 diff (99.8 %id) |
BF807284 | colon_ins | .a | 1277 to 1627 | 350 to 1 | | | Submitted on the opposite strand | 350/350 (100 %) | 4 diff (98.9 %id) |
BF988231 | placenta_normal | .a | 1277 to 1638 | 1 to 362 | | | | 362/362 (100 %) | 1 diff (99.8 %id) |
TI_1948224505 | | .a | 1321 to 2098 | 912 to 128 | | | | 785/1303 (60 %) | 12 diff (99.1 %id) |
BP233388 | coronary artery | .a | 1380 to 1834 | 1 to 455 | | | | 455/460 (98 %) | 1 diff (99.8 %id) |
BF971000 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 1387 to 2143 | 14 to 764 | | | | 751/764 (98 %) | 15 diff (98.1 %id) |
TI_1948225457 | | .a | 1410 to 2098 | 816 to 124 | | | | 693/1446 (47 %) | 17 diff (98.9 %id) |
TI_57192752 | | .a | 1647 to 2453 | 54 to 861 | | | | 808/809 (99 %) | 13 diff (98.4 %id) |
BI860768 | breast, mammary adenocarcinoma, cell line | .a | 1648 to 2453 | 1 to 807 | | | | 807/808 (99 %) | 13 diff (98.4 %id) |
BU963781 | mixed (pool of 40 RNAs) | .a | 1719 to 2461 | 1 to 755 | | | | 755/793 (95 %) | 24 diff (97.0 %id) |
BE256627 | eye, retinoblastoma | .a | 1840 to 2360 | 1 to 522 | | | | 522/522 (100 %) | 2 diff (99.7 %id) |
BG024791 | lymph, lymphoma, cell line | .a | 1846 to 2624 | 1 to 774 | | | | 774/982 (78 %) | 26 diff (97.4 %id) |
BX328038 | Placenta Cot 25-normalized | .a | 1912 to 2773 | 9 to 875 | | | | 867/882 (98 %) | 34 diff (96.2 %id) |
BP429338 | | .a | 1914 to 2296 | 1 to 383 | | | | 383/383 (100 %) | 3 diff (99.3 %id) |
TI_1948225140 | | .a | 1929 to 2098 | 296 to 127 | | | | 170/197 (86 %) | 0 diff (100 %id) |
BX381998 | Placenta Cot 25-normalized | .a | 1959 to 2276 | 627 to 308 | | fully sequenced, | | 320/627 (51 %) | 6 diff (99.1 %id) |
CX163222 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 1970 to 2608 | 664 to 26 | | fully sequenced, AAA | Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) | 639/639 (100 %) | 1 diff (99.9 %id) |
AW752967 | colon | .a | 2069 to 2210 | 163 to 21 | | | | 143/163 (87 %) | 1 diff (99.4 %id) |
AI653809 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 2111 to 2615 | 505 to 1 | | | | 505/505 (100 %) | 1 diff (99.9 %id) |
AL514669 | neuroblastoma, placenta | .a | 2180 to 2925 | 747 to 1 | | fully sequenced, | | 747/747 (100 %) | 43 diff (94.3 %id) |
AI866964 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 2192 to 2616 | 424 to 1 | | | | 424/424 (100 %) | 1 diff (99.8 %id) |
CD172494 | White Matter | .a | 2302 to 3121 | 1 to 830 | | | | 830/879 (94 %) | 13 diff (98.6 %id) |
CN430244 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 2479 to 3128 | 1 to 651 | | | | 651/651 (100 %) | 5 diff (99.3 %id) |
BQ021496 | lung, Metastatic Chondrosarcoma | .a | 2511 to 3056 | 18 to 564 | | AAA | Submitted on the opposite strand | 547/564 (96 %) | 6 diff (99.0 %id) |
BQ222497 | leiomyosarcoma, uterus | .a | 2527 to 3126 | 1 to 600 | | tiling clone, | | 600/1027 (58 %) | 9 diff (99.2 %id) |
BF059353 | pooled germ cell tumors | .a | 2601 to 2909 | 310 to 1 | | | | 310/310 (100 %) | 1 diff (99.7 %id) |
AA703412 | liver and spleen | .a | 2621 to 3054 | 434 to 1 | | | | 434/434 (100 %) | 0 diff (100 %id) |
BF223912 | pooled germ cell tumors | .a | 2667 to 3056 | 390 to 1 | | | | 390/390 (100 %) | 0 diff (100 %id) |
AV721197 | hypothalamus | .a | 2729 to 3322 | 1 to 590 | | | | 590/661 (89 %) | 19 diff (97.2 %id) |
DB323867 | | .a | 2906 to 3395 | 491 to 2 | | | | 490/491 (99 %) | 0 diff (100 %id) |
BC014022 | Primary B-Cells from Tonsils | .b | 1 to 1509 | 4 to 1511 | exact | tiling clone, available from MGC, AAA | | 1511/1511 (100 %) | 1 diff (100.0 %id) |
BP369333 | testis | .c | 1 to 576 | 1 to 576 | | | | 576/576 (100 %) | 3 diff (99.5 %id) |
AK058090 | testis | .c | 5 to 1284 | 1 to 1280 | C245G | tiling clone, available from FLJ, | | 1280/1280 (100 %) | 1 diff (100.0 %id) |
BP207270 | coronary artery | .c | 20 to 588 | 1 to 569 | | | | 569/569 (100 %) | 5 diff (99.2 %id) |
DB215303 | trachea | .c | 20 to 436 | 2 to 418 | | capped | | 417/417 (100 %) | 0 diff (100 %id) |
BC036904 | Bladder, transitional cell papilloma | .d | 1 to 1400 | 11 to 1410 | M207V | tiling clone, available from MGC, AAA | | 1400/1400 (100 %) | 1 diff (100.0 %id) |
BX112868 | liver and spleen | .d | 622 to 1058 | 55 to 491 | | tiling clone, | | 437/491 (89 %) | 6 diff (98.8 %id) |
H62715 | liver and spleen | .d | 622 to 1006 | 9 to 395 | | fully sequenced, | | 387/395 (97 %) | 10 diff (97.5 %id) |
AV697773 | hepatocellular carcinoma | .d | 954 to 1354 | 1 to 401 | | | | 401/404 (99 %) | 1 diff (99.8 %id) |
H62801 | liver and spleen | .d | 976 to 1329 | 368 to 1 | | fully sequenced, | | 368/368 (100 %) | 20 diff (94.6 %id) |
CD358564 | testis | .e | 1 to 856 | 1 to 860 | exact | tiling clone, | | 860/862 (99 %) | 15 diff (98.3 %id) |
CR456938 | | .e | 188 to 693 | 4 to 509 | | | | 509/513 (99 %) | 2 diff (99.7 %id) |
CV029503 | mixed | .e | 188 to 696 | 4 to 512 | | tiling clone, | | 512/666 (76 %) | 1 diff (99.9 %id) |
TI_1948098860 | | .e | 228 to 679 | 173 to 624 | | | | 452/524 (86 %) | 0 diff (100 %id) |
AW869169 | stomach_normal | .e | 419 to 833 | 1 to 414 | | tiling clone, | | 414/414 (100 %) | 17 diff (95.9 %id) |
BE836467 | prostate_normal | .e | 497 to 796 | 304 to 5 | | | | 300/311 (96 %) | 2 diff (99.4 %id) |
BU858370 | mixed (pool of 40 RNAs) | .f | 1 to 612 | 1 to 611 | A167P K179C Y180T I181L L182G | tiling clone, | | 611/817 (74 %) | 9 diff (98.9 %id) |
BX343213 | | .g | 1 to 413 | 1 to 508 | | tiling clone, | | 385/509 (75 %) | 14 diff (97.3 %id) |
DC384271 | | .g | 4 to 861 | 1 to 869 | L129V Q130T Q131A I132N V133C ... | tiling clone, | | 865/869 (99 %) | 21 diff (97.6 %id) |
DB136602 | thymus | .g | 8 to 267 | 2 to 262 | | capped | | 261/262 (99 %) | 4 diff (98.5 %id) |
CN271030 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .g | 26 to 259 | 8 to 241 | | | | 234/241 (97 %) | 6 diff (97.6 %id) |
AL558702 | T cells from T cell leukemia | .h | 1 to 354 | 1 to 355 | | tiling clone, | | 355/410 (86 %) | 7 diff (98.3 %id) |
AL120316 | amygdala | .h | 66 to 502 | 1 to 438 | | | | 438/439 (99 %) | 4 diff (99.1 %id) |
AL120273 | amygdala | .h | 75 to 473 | 1 to 400 | | | | 400/422 (94 %) | 13 diff (97.0 %id) |
BM468705 | leiomyosarcoma, uterus | .h | 78 to 865 | 31 to 820 | | | | 790/1050 (75 %) | 31 diff (97.1 %id) |
NM_000945.3 | | .h | 78 to 3088 | 1 to 3011 | exact | RefSeq, AAA | | 3011/3011 (100 %) | 0 diff (100 %id) |
BC027913 | Blood, adult leukocytes | .h | 82 to 3088 | 1 to 3006 | exact | tiling clone, available from MGC, AAA | | 3006/3006 (100 %) | 1 diff (100.0 %id) |
DA014034 | adrenal gland | .h | 101 to 375 | 2 to 276 | | capped | | 275/275 (100 %) | 0 diff (100 %id) |
M30773 | brain stem and basal ganglia | .h | 113 to 2259 | 403 to 2548 | exact | | | 2146/2548 (84 %) | 7 diff (99.8 %id) |
BX328365 | | .h | 167 to 937 | 1 to 775 | | | | 775/775 (100 %) | 52 diff (93.3 %id) |
DN994916 | brain, whole brain | .h | 342 to 935 | 1 to 594 | | | | 594/595 (99 %) | 5 diff (99.2 %id) |
AL528885 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .h | 397 to 1241 | 1 to 846 | Y7D Q81X | | | 846/846 (100 %) | 5 diff (99.5 %id) |
AA057205 | uterus | .h | 404 to 832 | 1 to 431 | | | Submitted on the opposite strand | 431/431 (100 %) | 4 diff (99.1 %id) |
AW904437 | nervous_normal | .h | 701 to 1207 | 7 to 513 | | | | 507/513 (98 %) | 11 diff (97.9 %id) |
BE936288 | nervous_normal | .h | 703 to 1180 | 1 to 478 | | | | 478/478 (100 %) | 8 diff (98.4 %id) |
AW892041 | nervous_tumor | .h | 709 to 1211 | 1 to 503 | | | | 503/505 (99 %) | 16 diff (96.9 %id) |
AW889884 | nervous_tumor | .h | 716 to 1222 | 1 to 507 | | | | 507/507 (100 %) | 3 diff (99.5 %id) |
CD651942 | Embryonic Stem cells | .h | 743 to 1386 | 136 to 775 | | | | 640/795 (80 %) | 27 diff (96.7 %id) |
BF082097 | breast_normal | .h | 823 to 1224 | 400 to 1 | | | | 400/400 (100 %) | 1 diff (99.8 %id) |
AW999475 | breast_normal | .h | 893 to 1241 | 357 to 12 | | | Submitted on the opposite strand | 346/357 (96 %) | 9 diff (97.5 %id) |
CX786778 | human embryonic stem cells | .h | 908 to 1315 | 1 to 408 | | AAA | | 408/420 (97 %) | 5 diff (98.9 %id) |
AI953601 | Kidney | .h | 937 to 1544 | 607 to 1 | | | | 607/786 (77 %) | 34 diff (95.7 %id) |
BI093844 | cervix | .h | 958 to 1731 | 1 to 773 | | | | 773/773 (100 %) | 7 diff (99.1 %id) |
AA985251 | schizophrenic brain S-11 frontal lobe | .h | 990 to 1381 | 397 to 4 | | | | 394/490 (80 %) | 0 diff (100 %id) |
DA266399 | caudate nucleus | .h | 1139 to 1687 | 2 to 550 | | capped | | 549/549 (100 %) | 1 diff (99.9 %id) |
AA018999 | eye, retina | .h | 1150 to 1458 | 1 to 317 | | | | 317/361 (87 %) | 9 diff (97.6 %id) |
AA019009 | eye, retina | .h | 1152 to 1594 | 1 to 443 | | | | 443/443 (100 %) | 0 diff (100 %id) |
AI078851 | senescent fibroblast | .h | 1203 to 1813 | 618 to 1 | | | | 618/618 (100 %) | 39 diff (93.7 %id) |
AA127129 | colon, tumor | .h | 1265 to 1662 | 1 to 400 | | | | 400/400 (100 %) | 2 diff (99.5 %id) |
BP350152 | brain | .h | 1336 to 1918 | 1 to 583 | | | | 583/583 (100 %) | 0 diff (100 %id) |
FN072127 | breast carcinoma | .h | 1361 to 1472 | 1 to 112 | | | | 112/112 (100 %) | 2 diff (98.3 %id) |
DA300390 | hippocampus | .h | 1418 to 1994 | 2 to 579 | | capped | | 578/578 (100 %) | 1 diff (99.9 %id) |
W05797 | lung | .h | 1442 to 1933 | 14 to 497 | | | | 484/497 (97 %) | 6 diff (98.8 %id) |
BM763382 | myeloma | .h | 1455 to 2077 | 1 to 623 | | | | 623/623 (100 %) | 0 diff (100 %id) |
BM468868 | embryonal carcinoma, cell line, testis | .h | 1459 to 2425 | 1 to 974 | | | | 974/1034 (94 %) | 19 diff (98.2 %id) |
AA193386 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .h | 1513 to 2102 | 1 to 590 | | | | 590/592 (99 %) | 11 diff (98.2 %id) |
AW892745 | nervous_normal | .h | 1534 to 1893 | 24 to 384 | | | | 361/384 (94 %) | 6 diff (98.5 %id) |
AA057017 | eye, retina | .h | 1581 to 1937 | 1 to 363 | | | | 363/363 (100 %) | 6 diff (98.4 %id) |
CR593156 | T cells (Jurkat cell line) Cot10-normalized | .h | 1587 to 3086 | 1 to 1500 | | tiling clone, | | 1500/1500 (100 %) | 0 diff (100 %id) |
BX340492 | | .h | 1587 to 2487 | 1 to 899 | | | | 899/899 (100 %) | 12 diff (98.7 %id) |
CB243698 | Human Lung Epithelial cells, lung | .h | 1606 to 2255 | 666 to 17 | | AAA | | 650/650 (100 %) | 0 diff (100 %id) |
BP339561 | Spleen | .h | 1610 to 2180 | 1 to 571 | | | | 571/571 (100 %) | 1 diff (99.9 %id) |
BF362387 | nervous_normal | .h | 1626 to 2010 | 17 to 401 | | | | 385/401 (96 %) | 6 diff (98.6 %id) |
BG742016 | skin | .h | 1654 to 2532 | 1 to 881 | | | | 881/885 (99 %) | 21 diff (97.7 %id) |
CF596747 | ovary | .h | 1659 to 2315 | 1 to 666 | | AAA | | 666/816 (81 %) | 14 diff (98.3 %id) |
BE503283 | pooled germ cell tumors | .h | 1694 to 2266 | 573 to 1 | | | | 573/623 (91 %) | 8 diff (98.8 %id) |
AI436114 | pooled | .h | 1715 to 2255 | 553 to 19 | | AAA | | 535/541 (98 %) | 26 diff (95.2 %id) |
BQ932182 | sciatic nerve | .h | 1757 to 2612 | 1 to 861 | | | | 861/888 (96 %) | 33 diff (96.3 %id) |
AA480156 | colon | .h | 1767 to 2255 | 481 to 1 | | | | 481/481 (100 %) | 12 diff (97.6 %id) |
AI335801 | uterus | .h | 1812 to 2258 | 447 to 1 | | | | 447/447 (100 %) | 0 diff (100 %id) |
AA442966 | ovarian tumor, ovary | .h | 1816 to 2190 | 1 to 375 | | | | 375/375 (100 %) | 19 diff (95.0 %id) |
BI553282 | brain, hippocampus | .h | 1921 to 2527 | 1 to 607 | | | | 607/607 (100 %) | 5 diff (99.2 %id) |
TI_44170291 | | .h | 1925 to 2527 | 90 to 692 | | | | 603/692 (87 %) | 6 diff (99.2 %id) |
AI698980 | adenocarcinoma, Pancreas | .h | 1982 to 2259 | 279 to 4 | | | | 276/279 (98 %) | 0 diff (100 %id) |
AA736594 | germinal center B cell | .h | 2000 to 2262 | 269 to 9 | | | | 261/269 (97 %) | 0 diff (100 %id) |
AW582671 | stomach | .h | 2004 to 2532 | 1 to 546 | | | | 546/548 (99 %) | 24 diff (95.7 %id) |
BM854313 | stomach | .h | 2004 to 2414 | 1 to 411 | | | | 411/411 (100 %) | 2 diff (99.6 %id) |
AL580466 | T cells from T cell leukemia | .h | 2025 to 3042 | 1044 to 20 | | | | 1025/1044 (98 %) | 61 diff (94.2 %id) |
AW610144 | stomach | .h | 2031 to 2558 | 1 to 532 | | | | 532/537 (99 %) | 36 diff (93.3 %id) |
CK024189 | brain/CNS, Human Brain - Frontal Cortex | .h | 2045 to 2734 | 1 to 687 | | | | 687/691 (99 %) | 10 diff (98.6 %id) |
BQ228635 | melanotic melanoma, skin | .h | 2055 to 2930 | 1 to 878 | | | | 878/878 (100 %) | 4 diff (99.6 %id) |
AI151458 | placenta | .h | 2072 to 2633 | 573 to 12 | | AAA | | 562/562 (100 %) | 9 diff (98.4 %id) |
BM782908 | myeloma | .h | 2073 to 2506 | 1 to 436 | | | | 436/436 (100 %) | 5 diff (98.9 %id) |
DA321100 | hippocampus | .h | 2114 to 2681 | 2 to 569 | | capped | | 568/568 (100 %) | 6 diff (99.0 %id) |
AL563277 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .h | 2172 to 2954 | 901 to 112 | | | | 790/814 (97 %) | 0 diff (100 %id) |
BX352202 | | .h | 2172 to 3081 | 912 to 6 | | | | 907/923 (98 %) | 0 diff (100 %id) |
BF372272 | prostate_tumor | .h | 2173 to 2554 | 13 to 394 | | | | 382/394 (96 %) | 6 diff (98.5 %id) |
BX349081 | | .h | 2215 to 2947 | 1 to 732 | | | | 732/792 (92 %) | 4 diff (99.5 %id) |
EH307788 | | .h | 2269 to 2335 | 1 to 67 | | | | 67/67 (100 %) | 0 diff (100 %id) |
BQ364530 | stomach | .h | 2303 to 2489 | 7 to 193 | | | | 187/193 (96 %) | 6 diff (96.9 %id) |
CD250743 | Blood vessels - aorta, basilar and artery | .h | 2322 to 2840 | 1 to 526 | | | | 526/848 (62 %) | 11 diff (98.8 %id) |
FN158895 | breast carcinoma | .h | 2400 to 2452 | 1 to 52 | | | | 52/52 (100 %) | 1 diff (98.1 %id) |
BP244415 | Kidney | .h | 2410 to 2915 | 1 to 506 | | | | 506/581 (87 %) | 4 diff (99.4 %id) |
AL544951 | placenta, Placenta Cot 25-normalized | .h | 2490 to 3088 | 1 to 602 | | AAA | | 602/602 (100 %) | 1 diff (99.9 %id) |
AL544795 | placenta, Placenta Cot 25-normalized | .h | 2490 to 3088 | 1 to 602 | | AAA | | 602/602 (100 %) | 1 diff (99.9 %id) |
BE540381 | cervix | .h | 2566 to 2945 | 1 to 381 | | | | 381/544 (70 %) | 5 diff (99.1 %id) |
AW026853 | brain, glioblastoma (pooled) | .h | 2605 to 3088 | 488 to 3 | | | | 486/488 (99 %) | 0 diff (100 %id) |
AI808302 | pooled | .h | 2630 to 3088 | 477 to 14 | | AAA | | 464/465 (99 %) | 16 diff (96.6 %id) |
BF803985 | colon_ins | .h | 2645 to 2912 | 26 to 294 | | | | 269/296 (90 %) | 14 diff (95.3 %id) |
BX332708 | Neuroblastoma Cot 25-normalized | .h | 2689 to 3088 | 1 to 405 | | AAA | | 405/405 (100 %) | 6 diff (98.6 %id) |
FN091377 | breast carcinoma | .h | 2699 to 2798 | 1 to 97 | | | | 97/101 (96 %) | 7 diff (93.1 %id) |
N75061 | lung | .h | 2767 to 3088 | 330 to 1 | | | | 330/335 (98 %) | 3 diff (99.2 %id) |
AA768956 | germinal center B cell | .h | 2877 to 3088 | 238 to 23 | | AAA | | 216/216 (100 %) | 4 diff (98.2 %id) |
AA018907 | eye, retina | .h | 2888 to 3088 | 213 to 11 | | AAA | | 203/203 (100 %) | 3 diff (98.6 %id) |
AA283054 | germinal center B cell | .h | 2974 to 3088 | 125 to 11 | | AAA | | 115/115 (100 %) | 0 diff (100 %id) |
DB466336 | hippocampus | .i | 1 to 414 | 1 to 415 | | tiling clone, | | 415/415 (100 %) | 28 diff (93.3 %id) |
BX485177 | | .i | 45 to 728 | 9 to 690 | K155R M156W V157W V158* | tiling clone, | | 682/690 (98 %) | 8 diff (98.9 %id) |
TI_1948098589 | | .j | 1 to 478 | 153 to 630 | L2X V3X D4* | tiling clone, fully sequenced, | | 478/630 (75 %) | 15 diff (97.7 %id) |
TI_1948098590 | | .j | 91 to 478 | 516 to 128 | | tiling clone, fully sequenced, | | 389/516 (75 %) | 0 diff (100 %id) |
AW173358 | pooled | .k | 1 to 528 | 530 to 3 | exact | tiling clone, | | 528/530 (99 %) | 0 diff (100 %id) |
AW014787 | | .k | 32 to 521 | 507 to 18 | | AAA | | 490/490 (100 %) | 0 diff (100 %id) |
AI285866 | pooled | .k | 109 to 528 | 422 to 3 | | | | 420/422 (99 %) | 0 diff (100 %id) |
AA825966 | germinal center B cell | .k | 145 to 521 | 396 to 21 | | AAA | | 376/376 (100 %) | 1 diff (99.8 %id) |
AK090527 | adrenal gland | .k | 452 to 2134 | 1 to 1686 | | tiling clone, available from FLJ, | | 1686/1686 (100 %) | 12 diff (99.3 %id) |
DA014923 | adrenal gland | .k | 453 to 967 | 2 to 516 | | capped | | 515/515 (100 %) | 2 diff (99.7 %id) |
DB295389 | adrenal gland | .k | 1602 to 2134 | 533 to 1 | | | | 533/533 (100 %) | 7 diff (98.7 %id) |
BX109819 | liver and spleen | .l-u | 1 to 552 | 1 to 552 | | tiling clone, | | 552/552 (100 %) | 0 diff (100 %id) |
H37886 | liver and spleen | .l-u | 2 to 397 | 1 to 402 | | | | 402/425 (94 %) | 12 diff (97.2 %id) |
H37832 | liver and spleen | .l-u | 636 to 955 | 333 to 9 | | tiling clone, | | 325/359 (90 %) | 0 diff (100 %id) |
AA226547 | | .l-u | 930 to 1370 | 1 to 443 | | tiling clone, | | 443/446 (99 %) | 8 diff (98.3 %id) |
AA226211 | | .l-u | 1221 to 1642 | 426 to 5 | I36X Y38X F46X Q50X L51A ... | tiling clone, | | 422/430 (98 %) | 0 diff (100 %id) |
BP206493 | coronary artery | .m | 12 to 591 | 1 to 582 | | tiling clone, | | 582/582 (100 %) | 2 diff (99.7 %id) |
CN272192 | embryonic stem cells, DMSO-treated H9 cellline | .m | 28 to 494 | 1 to 467 | | | | 467/467 (100 %) | 2 diff (99.6 %id) |
CX758616 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .m | 609 to 710 | 641 to 740 | T16S N31T L32F H33N I34M | tiling clone, | Submitted on the opposite strand | 722/779 (92 %) | 10 diff (98.8 %id) |
BE348414 | carcinoid, lung | .n-u | 1 to 504 | 504 to 1 | exact | tiling clone, | | 504/504 (100 %) | 2 diff (99.7 %id) |
BF326932 | breast_normal | .o-u | 1 to 320 | 35 to 353 | exact | tiling clone, | | 319/353 (90 %) | 6 diff (98.4 %id) |
AV707573 | adrenal gland | Gene PPP3R1andWDR92, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AK307136 | hippocampus | Gene PPP3R1andWDR92, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AK314893 | | Gene PPP3R1andWDR92, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AL834142 | testis | Gene PPP3R1andWDR92, variant not shown | | | | available from DKFZ, AAA | This clone was ignored | | |
DC299288 | | Gene PPP3R1andWDR92, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
BI001378 | head_normal | Gene PPP3R1andWDR92, variant not shown | | | | | | | |
DB305019 | brain | Gene PPP3R1andWDR92, variant not shown | | | | | This clone was ignored | | |
DA221794 | brain | Gene PPP3R1andWDR92, variant not shown | | | | capped | This clone was ignored | | |
DC332208 | hippocampus | Gene PPP3R1andWDR92, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AL540005.
matches multiple genes | brain, fetal brain | Gene PPP3R1andWDR92, variant not shown | | | | | This clone was ignored, also hits gene C1D | | |
AL540005.
matches multiple genes | brain, fetal brain | Gene C1D, variant not shown | | | | | This clone was ignored, also hits gene C1D | | |
AL540006.
matches multiple genes | brain, fetal brain | Gene PPP3R1andWDR92, variant not shown | | | | | This clone was ignored, also hits gene C1D | | |
AL540006.
matches multiple genes | brain, fetal brain | Gene C1D, variant not shown | | | | | This clone was ignored, also hits gene C1D | | |
CA395388 | eye, RPE/choroid | Gene PPP3R1andWDR92, variant not shown | | | | | | | |
DB506792 | testis | Gene PPP3R1andWDR92, variant not shown | | | | | This clone was ignored | | |
DB441867 | testis | Gene PPP3R1andWDR92, variant not shown | | | | | This clone was ignored | | |
AA001820 | liver and spleen | Gene PPP3R1andWDR92, variant not shown | | | | | | | |
AA002024 | liver and spleen | Gene PPP3R1andWDR92, variant not shown | | | | | | | |
AA278497 | germinal center B cell | Gene PPP3R1andWDR92, variant not shown | | | | | This clone was ignored | | |
AA279031 | germinal center B cell | Gene PPP3R1andWDR92, variant not shown | | | | | This clone was ignored | | |
BP310803 | brain | Gene PPP3R1andWDR92, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
? | Gene Summary |
Gene on genome |
mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n-u, .o-u |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes DCI |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !